DrugAnalyst is voted the leading independent Pharmaceuticals Equity Research provider
We provide global healthcare stock coverage and a database containing 10-years of sell-side broker consensus estimates. People make money selling consensus.
We make our money analysing it!
Our drug consensus estimates are refreshed on a daily basis, all the numbers here are based on new numbers published since the release of last quarter’s financial results. It means all the numbers have the same inputs behind them. No-one else does this.
The entire database is published once a quarter within our subscription only Global Pharma Workbook.
Full access to our consensus data is free to subscribers of DrugAnalyst Equity Research. For Subscription Enquiries please contact us.